Sputnik V

Sputnik Light, the Single Dose Version of Sputnik V Authorized in Russia

Yesterday, 6th April 2021, the Russian Ministry of Health, the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced that Sputnik Light, a single dose COVID-19 vaccine, has received authorization for use in Russia.

Sputnik Light, the Single Dose Version of Sputnik V Authorized in Russia Read More

Sputnik V; the Russian Weapon Against the COVID 19 Pandemic

Sputnik V vaccine, a product of Russian Research facility, Gamaleya Research Institute of Epidemiology and Microbiology is one of the main vaccination candidate Sri Lanka is looking forward to acquire in mass scale. The first consignment of Sputnik V Vaccine with 15000 doses arrived in Sri Lanka yesterday, 4th May 2021. According to state officials Sri Lanka is to receive 13 million doses of this Sputnik V vaccine in near future.

Sputnik V; the Russian Weapon Against the COVID 19 Pandemic Read More
RT-LAMP by SLINTEC

SLINTEC Obtains NMRA GMP License for Their COVID Test Kit, Commercial Manufacturing to Commence Soon

In a special press release today, 1st of May 2021 the Sri Lanka Institute of Nanotechnology (SLINTEC) announced obtaining the GMP license from NMRA for manufacturing their COVID 19 Rapid Test Kit RT-LAMP.

SLINTEC Obtains NMRA GMP License for Their COVID Test Kit, Commercial Manufacturing to Commence Soon Read More
b.1.1.7

COVID Variant B.1.1.7: Some Key Facts You Should Know

In a special announcement today the scientists at Sri Jayewardenepura University revealed the COVID 19 virus strain behind the recent increase of the cases to be the variant B.1.1.7 which was first identified in United Kingdom during the month September 2020. According to the observations in UK this variant was found to be associated with increased admissibility and higher virulance.

COVID Variant B.1.1.7: Some Key Facts You Should Know Read More
Vitamin D

Vitamin D determines severity in COVID-19: Irish research

A recent research conducted by a team in Triniy Collage, Dublin, Ireland shows a possible involvement of Vitamin D levels of Covid 19 patients towards low mortality rates. The team had done this study using Vitamin D data available online about the European countries affected by COVID 19 and the Covid 19 mortality rates of those countries as reported by WHO.

Vitamin D determines severity in COVID-19: Irish research Read More

Men’s blood contains greater concentrations of ACE2 enzyme making them more susceptible to COVID-19

One of the most remarkable observation with COVID 19 disease was that males are more vulnerable to this virus than females. As given in the graph below, in many countries men are at a significantly higher risk of having severe symptoms and dying when compared to women. A recent study study, published in the European Heart Journal on 11th May (Monday), has been able to give a clear explanation to this observation. The study done by a team headed by Dr Adriaan Voors (MD-PhD), Professor of Cardiology at the University Medical Center Groningen (The Netherlands) was aimed at finding the effect of renin–angiotensin–aldosterone system (RAAS) inhibitors on ACE2 concentrations in blood plasma.

Men’s blood contains greater concentrations of ACE2 enzyme making them more susceptible to COVID-19 Read More
Prof. Rangika

COVID-19 pandemic, an ideal opportunity for innovation?

Innovation is a new idea, creative thought or a new imagination in the form of a device or a method which originates as a solution to a problem. When there are more problems around, more innovations come up. During the world war ii many new inventions ranging from antibiotics to rocket technologies. Many of those inventions were a result of the hardship people had to go through during those difficult and challenging times. At present COVID 19 pandemic has created such scenario where the entire human population facing one of the biggest challenges the world has ever faced creating many problems individually and socially. We can see individuals and organizations going after answers or solutions for those problems paving the way to many innovations and inventions throughout the world.

COVID-19 pandemic, an ideal opportunity for innovation? Read More